Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
salbutamol + guaifenesin
- Development stage
- Unknown
- Lead developer
- GSK
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Salbutamol + guaifenesin is a **combination pharmaceutical drug** consisting of salbutamol, a selective beta-2 adrenoceptor agonist bronchodilator, and guaifenesin, an expectorant. Salbutamol relaxes bronchial smooth muscle to relieve bronchospasm and improve airflow in conditions such as asthma, chronic bronchitis, and emphysema. Guaifenesin decreases the viscosity of bronchial secretions, promoting easier expectoration. The combination is primarily used for **cough associated with mucus congestion** and respiratory disorders characterized by bronchospasm and excessive mucus, including bronchial asthma, chronic bronchitis, and emphysema[1][2][3][5][9].
- Brand names
- VentorlinSalbusunHistonate PlusSalfinAsthaphatSurfesinVentolin ExpectorantVENTO-BRONCHO GMucosyd
- Other names
- salbutamol + guaifenesinguaifenesin + salbutamol
02
Targets
ADRB2 (β2)
Beyond the preview
Go deeper on salbutamol + guaifenesin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on salbutamol + guaifenesin.